The Effect of Intravenous Acetaminophen on Post-Operative Pain After Craniotomy
NCT ID: NCT03445390
Last Updated: 2019-03-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
27 participants
INTERVENTIONAL
2014-05-01
2017-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period
NCT01739699
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
NCT01948505
Intravenous Acetaminophen in Craniotomy
NCT01598701
Use of IV Acetaminophen in the Treatment of Post Operative Pain in Patients Undergoing Craniotomy and Spine Surgery
NCT03261310
Pain Control After Cardiac Surgery Using Intravenous Acetaminophen
NCT01822821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acetaminophen First
Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive acetaminophen first.
Acetaminophen
Acetaminophen 1 g intravenous given at the beginning and end of surgery.
Placebo
Placebo to match acetaminophen given at the beginning and end of surgery.
Placebo First
Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive placebo first.
Acetaminophen
Acetaminophen 1 g intravenous given at the beginning and end of surgery.
Placebo
Placebo to match acetaminophen given at the beginning and end of surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acetaminophen
Acetaminophen 1 g intravenous given at the beginning and end of surgery.
Placebo
Placebo to match acetaminophen given at the beginning and end of surgery.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Burbridge
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University Medical Center
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
27467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.